Week 2 – Tissue Engineering Part 2: Comprehensive Study Notes
Tissue Injury and the Promise of Regenerative Medicine
The adult body often fails to repair severe tissue damage because its intrinsic self-repair capacity diminishes with age, limited stem-/progenitor-cell numbers, naturally low regenerative potential in some tissues, and maladaptive inflammatory responses. Tissue engineering (TE) and regenerative medicine therefore focus on ex vivo or in vivo strategies that actively replace or restore damaged structures.
The Biological Building Blocks of Organs
Organs are hierarchically organised combinations of four fundamental soft-tissue types:
Epithelial tissue – layers of cells that coat surfaces and create a barrier between the external and internal milieu; present in skin and all hollow organs.
Connective tissue – elastic matrices (tendons), load-bearing composites (cartilage), and specialised storage/transport media (fat, blood, lymphoid tissue).
Muscle tissue – contractile fibres enabling motion.
Nervous tissue – long-distance electrical/chemical signalling networks.
Functionally, each organ separates into parenchyma (epithelial, muscle, or neural cells executing the key task) supported by stroma (connective tissue, vasculature, nerves). The stroma provides nutrients, mechanical integrity, and informational cues to the parenchyma.
Cell-Based Therapies: Potentials and Pitfalls
Direct transplantation of stem or progenitor cells rarely succeeds because only a small fraction reaches, integrates, and survives within the injury site. In brain-repair studies, human cortical progenitors implanted after stroke showed better survival, reduced atrophy, and improved function when delivered within peptide-based scaffolds (Somaa et al., Cell Reports, 2017). The scaffold supplies structure, trophic factors, and spatial cues.
Biomaterials: Synthetic Scaffolds That Behave Biologically
The U.S. NIH defines a biomaterial as “any substance or combination of substances, other than drugs, synthetic or natural in origin, used ≥ any period of time to augment or replace tissues, organs, or bodily functions so as to improve quality of life.” In TE, biomaterials are designed to mimic and/or stimulate natural tissue function and to guide cell fate.
What Exactly Is Being Mimicked? – The Extracellular Matrix (ECM)
The ECM is a dynamic, hydrated microenvironment containing:
• Structural proteins – fibronectin, multiple collagens, elastin.
• Glycosaminoglycans (GAGs) – hyaluronic acid, chondroitin sulfate.
• Proteoglycans – aggrecan, perlecan.
• Non-structural matricellular proteins – tissue-specific regulators.
The ECM constantly remodels, generates bulk tissue mechanics (strength, elasticity), stores growth factors, and transmits biochemical as well as mechanical signals.
Cell–ECM Communication
Cells attach via surface integrins that cluster into adhesion complexes (vinculin, talin, F-actin). Outside-in signalling activates pathways such as ERK/MAPK, PI3K/AKT, JNK, and focal-adhesion kinase (FAK), governing survival, migration, proliferation, and differentiation.
Muscle Tissue: Organisation and Disease Illustration
A skeletal-muscle fibre houses parallel myofibrils (≈ wide) segmented into repeating sarcomeres (≈ when relaxed). Sliding of thick (myosin) and thin (actin) filaments shortens sarcomeres and generates contraction.
Case Study: Duchenne Muscular Dystrophy (DMD)
The zebrafish softy mutant (lacking Lamb2) can develop new myosepta but fails to stabilise muscle because laminin β2 is missing. Laminin is critical for basement-membrane (BM) integrity. Researchers created an enzyme-triggered self-assembling peptide/protein hydrogel that locally delivers laminin, restoring structural support (Williams et al., Biomaterials, 2011).
Basement Membranes (BMs): Thin Yet Mighty Interfaces
BMs are evolutionarily conserved, sheet-like ECMs lining the basal side of epithelia/endothelia and enveloping muscle, fat, and Schwann cells.
• Structure: Inner laminin-rich layer and collagen IV-rich layer interconnected by nidogen and heparan-sulfate proteoglycans (perlecan, agrin).
• Laminin 111 self-assembles by three-arm interactions once anchored to cell surfaces (via integrins, α-dystroglycan, sulfatides). This 2-D confinement raises local laminin concentration, promoting sheet formation.
• Collagen IV adds covalent cross-linking, enabling the BM to withstand mechanical stress.
BM-Directed Cell Polarity and Tissue Morphogenesis
– MDCK cysts secrete laminin basally; accumulated laminin instructs apico-basal polarity and lumen formation. Blocking secretion disrupts orientation.
– In C. elegans, laminin deposition precedes PAR-6/PAR-3 apical localisation, enabling pharyngeal lumen shaping.
– Eye morphogenesis involves epithelial flow regulated by BM modulation (eLife study referenced).
3-D Connective Tissue Microenvironments
Within connective tissues, cells are surrounded by ECM on all sides:
• Composition and fibre orientation dictate matrix stiffness and ligand spacing.
• Cells bind via integrins, exert traction, and mechanically communicate over distance.
• Gradients in cross-linking or stiffness can be physiological or pathological (fibrosis, tumour stroma).
Mesenchymal Stem Cells (MSCs): Versatile Workhorses
MSCs are plastic-adherent, fibroblast-like, colony-forming multipotent cells isolated from bone marrow, placenta, skin, etc. They differentiate into osteoblasts, chondrocytes, adipocytes (and controversially neurons, myocytes). Their natural niche contains collagen I, fibronectin, and other ECM constituents.
Mechanotransduction Governs MSC Fate
Cells sense substrate stiffness via integrin adhesions linked to actomyosin stress fibres; contractile tension feeds back to signalling cascades and gene expression.
• Rigid matrices (bone-like) bias MSCs toward osteogenesis.
• Soft matrices (fat-like) bias toward adipogenesis.
Thus, engineering biomaterials with tissue-specific mechanical and biochemical cues can direct MSC differentiation – e.g., myoblasts on muscle-mimetic hydrogels, chondrocytes on cartilage-mimetic scaffolds.
ECM Turnover During Differentiation
Differentiating MSCs both remodel and respond to ECM: matrix metalloproteinases (MMPs) and tissue inhibitors (TIMPs, RECK) regulate degradation versus deposition, influencing cell migration, lineage commitment, and tissue homeostasis.
Design Principles and Practical Implications
Mimicry – Reproduce ECM/BM composition, architecture, and stiffness relevant to the target tissue.
Signal Integration – Combine biochemical (growth factors, integrin-binding motifs) and biophysical (topography, elasticity) cues.
Cell Retention & Delivery – Scaffolds protect transplanted cells, localise them, and release payloads (e.g., laminin) in situ.
Dynamic Remodeling – Materials should permit protease-mediated degradation and allow native ECM deposition.
Ethical/Clinical – Autologous MSCs avoid immune rejection; synthetic, xeno-free scaffolds reduce zoonotic risk. Regulatory pathways must balance innovation with patient safety.
Outlook
Emerging biomaterials seek to recapitulate not only static ECM features but also temporal dynamics: staged release of morphogens, stiffness gradients, and cell-responsive degradability. Coupled with gene-edited stem cells and in silico design, TE aspires to fabricate functional tissues and organs, potentially alleviating shortages in transplantation and transforming chronic disease management.